FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Dirk Felmeden

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Endothelium, Vascular

Concepts & Ideas

Physiology

Platelet Activation

Co-author Network

Publications

TOP 3
Charles G C Spencer; Dirk C Felmeden; Andrew D Blann; Gregory Y H Lip
Effects of "newer" and "older" antihypertensive drugs on hemorrheological, platelet, and endothelial factors. A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Charles G C Spencer; Dirk C Felmeden; Andrew D Blann; G Y H Lip
Haemorheological, platelet and endothelial indices in relation to global measures of cardiovascular risk in hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Dirk C Felmeden; Gregory Y H Lip
Endothelial function and its assessment.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Dirk Felmeden (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Charles G C Spencer; Dirk C Felmeden; Andrew D Blann; Gregory Y H Lip
Effects of "newer" and "older" antihypertensive drugs on hemorrheological, platelet, and endothelial factors. A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
American journal of hypertension 2007;20(6):699-704.
2007: Charles G C Spencer; Dirk C Felmeden; Andrew D Blann; G Y H Lip
Haemorheological, platelet and endothelial indices in relation to global measures of cardiovascular risk in hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Journal of internal medicine 2007;261(1):82-90.
2005: Dirk C Felmeden; Gregory Y H Lip
Endothelial function and its assessment.
Expert opinion on investigational drugs 2005;14(11):1319-36.
2005: Dirk C Felmeden; Sunil Nadar; G Y H Lip
Aspirin and endothelial function in hypertension.
Journal of human hypertension 2005;19(9):663-5.
2005: Dirk C Felmeden; G Y H Lip
Antithrombotic therapy in hypertension: a Cochrane Systematic review.
Journal of human hypertension 2005;19(3):185-96.
2004: Charles G C Spencer; Steven C Martin; Dirk C Felmeden; Andrew D Blann; Gareth D Beevers; Gregory Y H Lip
Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
International journal of cardiology 2004;94(2-3):293-300.
2004: Charles G C Spencer; David Gurney; Dirk C Felmeden; Andrew D Blann; D Gareth Beevers; G Y H Lip
Platelet and haemorheological markers in 'high risk' hypertensives are improved by tighter blood pressure control and cardiovascular risk management: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Journal of internal medicine 2004;255(1):59-67.
2003: Dirk C Felmeden; Charles G C Spencer; Natali A Y Chung; Funmi M Belgore; Andrew D Blann; D Gareth Beevers; Gregory Y H Lip
Relation of thrombogenesis in systemic hypertension to angiogenesis and endothelial damage/dysfunction (a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial [ASCOT]).
The American journal of cardiology 2003;92(4):400-5.
2003: Dirk C Felmeden; Andrew D Blann; Charles G C Spencer; D Gareth Beevers; G Y H Lip
A comparison of flow-mediated dilatation and von Willebrand factor as markers of endothelial cell function in health and in hypertension: relationship to cardiovascular risk and effects of treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2003;14(5):425-31.
2003: Dirk C Felmeden; Andrew D Blann; G Y H Lip
Angiogenesis: basic pathophysiology and implications for disease.
European heart journal 2003;24(7):586-603.
2003: Dirk C Felmeden; Charles G C Spencer; Andrew D Blann; D Gareth Beevers; Gregory Y H Lip
Low-density lipoprotein subfractions and cardiovascular risk in hypertension: relationship to endothelial dysfunction and effects of treatment.
Hypertension 2003;41(3):528-33.
2003: Dirk C Felmeden; Charles G C Spencer; Andrew D Blann; D Gareth Beevers; G Y H Lip
Physical activity in relation to indices of endothelial function and angiogenesis factors in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Journal of internal medicine 2003;253(1):81-91.
2003: Dirk C Felmeden; Charles G C Spencer; Funmi M Belgore; Andrew D Blann; D Gareth Beevers; Gregory Y H Lip
Endothelial damage and angiogenesis in hypertensive patients: relationship to cardiovascular risk factors and risk factor management.
American journal of hypertension 2003;16(1):11-20.
2002: Peck Lin Lip; Dirk C Felmeden; Andrew D Blann; N Matheou; S Thakur; I A Cunliffe; G Y H Lip
Plasma vascular endothelial growth factor, soluble VEGF receptor FLT-1, and von Willebrand factor in glaucoma.
The British journal of ophthalmology 2002;86(11):1299-302.
2002: Kaeng W Lee; Dirk C Felmeden; Gregory Y H Lip
Statins and the assessment of endothelial function.
Journal of internal medicine 2002;251(5):452-3; author reply 453-4.
2002: Kaeng W Lee; Dirk C Felmeden; Gregory Y H Lip
Lipid lowering and the assessment of endothelial function.
Cardiovascular research 2002;54(1):191-2; author reply 193-4.
2001: Dirk C Felmeden; Gregory Y H Lip; Gareth D Beevers
Calcium antagonists in diabetic hypertension.
Diabetes, obesity & metabolism 2001;3(5):311-8.
2001: Dirk C Felmeden; Gregory Y H Lip
Resistant hypertension and the Birmingham Hypertension Square.
Current hypertension reports 2001;3(3):203-8.
2001: Dirk C Felmeden; J G Gearty; D M Dawkins; Gareth D Beevers
Hypertension due to a giant aldosterone-secreting adenoma.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2001;2(1):43-4.
2001: Dirk C Felmeden; G Y Lip
Antihypertensive therapy and cancer risk.
Drug safety : an international journal of medical toxicology and drug experience 2001;24(10):727-39.
2000: Dirk C Felmeden; Gregory Y H Lip
Myocardial bridging.
International journal of clinical practice 2000;54(8):542-3.
2000: Gregory Y H Lip; Dirk C Felmeden; Foo Leong Li-Saw-Hee; D Gareth Beevers
Hypertensive heart disease. A complex syndrome or a hypertensive 'cardiomyopathy'?
European heart journal 2000;21(20):1653-65.
2000: Dirk C Felmeden; S P Singh; Gregory Y H Lip
Anomalous coronary arteries of aortic origin.
International journal of clinical practice 2000;54(6):390-4.
2000: Dirk C Felmeden; Gregory Y H Lip; Michele Beevers; D Gareth Beevers
The placebo effect and white coat effect in isolated systolic hypertension and systo-diastolic hypertension.
Blood pressure 2000;9(6):335-9.
2000: Dirk C Felmeden; Gregory Y H Lip
Hormone replacement therapy and hypertension.
Blood pressure 2000;9(5):246-9.
1997: Dirk C Felmeden; Gregory Y H Lip; D Gareth Beevers
Fibromuscular dysplasia.
Journal of human hypertension 1997;11(10):687-8.